Baillie Gifford
Auto Added by WPeMatico
Brazil’s Loft adds $100M to its accounts, $700M to its valuation in a single month
Nearly exactly one month ago, digital real estate platform Loft announced it had closed on $425 million in Series D funding led by New York-based D1 Capital Partners. The round included participation from a mix of new and existing investors such as DST, Tiger Global, Andreessen Horowitz, Fifth Wall and QED, among many others.
At the time, Loft was valued at $2.2 billion, a huge jump from its being just near unicorn territory in January 2020. The round marked one of the largest ever for a Brazilian startup.
Now, today, São Paulo-based Loft has announced an extension to that round with the closing of $100 million in additional funding that values the company at $2.9 billion. This means that the 3-year-old startup has increased its valuation by $700 million in a matter of weeks.
Baillie Gifford led the Series D-2 round, which also included participation from Tarsadia, Flight Deck, Caffeinated and others. Individuals also put money in the extension, including the founders of Better (Zach Frenkel), GoPuff, Instacart, Kavak and Sweetgreen.
Loft has seen great success in its efforts to serve as a “one-stop shop” for Brazilians to help them manage the home buying and selling process.
Image Credits: Loft
In 2020, Loft saw the number of listings on its site increase “10 to 15 times,” according to co-founder and co-CEO Mate Pencz. Today, the company actively maintains more than 13,000 property listings in approximately 130 regions across São Paulo and Rio de Janeiro, partnering with more than 30,000 brokers. Not only are more people open to transacting digitally, more people are looking to buy versus rent in the country.
“We did more than 6x YoY growth with many thousands of transactions over the course of 2020,” Pencz told TechCrunch at the time of the company’s last raise. “We’re now growing into the many tens of thousands, and soon hundreds of thousands, of active listings.”
The decision to raise more capital so soon was due to a variety of factors. For one, Loft has received “overwhelming investor interest” even after “a very, very oversubscribed main round,” Pencz said.
“We have seen a continued acceleration in our market share growth, especially in São Paulo and Rio de Janeiro, the two markets we currently operate in,” he added. “We saw an opportunity to grow even faster with additional capital.”
Pencz also pointed out that Baillie Gifford has relatively large minimum check size requirements, which led to the extension being conducted at a higher price and increased the total round size “by quite a bit to be able to accommodate them.”
While the company was less forthcoming about its financials as of late, it told me last year that it had notched “over $150 million in annualized revenues in its first full year of operation” via more than 1,000 transactions.
The company’s revenues and GMV (gross merchandise value) “increased significantly” in 2020, according to Pencz, who declined to provide more specifics. He did say those figures are “multiples higher from where they were,” and that Loft has “a very clear horizon to profitability.”
Pencz and Florian Hagenbuch founded Loft in early 2018 and today serve as its co-CEOs. The aim of the platform, in the company’s words, is “bringing Latin American real estate into the e-commerce age by developing online alternatives to analogue legacy processes and leveraging data to create transparency in highly opaque markets.” The U.S. real estate tech company with the closest model to Loft’s is probably Zillow, according to Pencz.
In the United States, prospective buyers and sellers have the benefit of MLSs, which in the words of the National Association of Realtors, are private databases that are created, maintained and paid for by real estate professionals to help their clients buy and sell property. Loft itself spent years and many dollars in creating its own such databases for the Brazilian market. Besides helping people buy and sell homes, it offers services around insurance, renovations and rentals.
In 2020, Loft also entered the mortgage business by acquiring one of the largest mortgage brokerage businesses in Brazil. The startup now ranks among the top-three mortgage originators in the country, according to Pencz. When it comes to helping people apply for mortgages, he likened Loft to U.S.-based Better.com.
This latest financing brings Loft’s total funding raised to an impressive $800 million. Other backers include Brazil’s Canary and a group of high-profile angel investors such as Max Levchin of Affirm and PayPal, Palantir co-founder Joe Lonsdale, Instagram co-founder Mike Krieger and David Vélez, CEO and founder of Brazilian fintech Nubank. In addition, Loft has also raised more than $100 million in debt financing through a series of publicly listed real estate funds.
Loft plans to use its new capital in part to expand across Brazil and eventually in Latin America and beyond. The company is also planning to explore more M&A opportunities.
This article was updated post-publication to reflect accurate investor information.
Powered by WPeMatico
Why Florida residents may soon be seeing jet-powered ‘flying taxis’
Florida is renowned for its strange news stories. In recent weeks alone, one resident reported an alligator in her garage that turned out to be a pool floatie; another discovered a python in her washing machine; and a horse needed to be pulled out of a septic tank by firefighters.
Still, don’t dismiss Orlando residents who report seeing flying taxis overhead, because they may just be coming. Lilium Aviation, a five-year-old, Munich, Germany-based, venture-backed startup that designs and makes electric vertical take-off and landing jets, is reportedly seeking tax incentives from the city to build a 56,000-square-foot transportation hub with the promise that it will create 100 high-wage jobs in return.
According to the Orlando Business Sentinel, the proposed facility — a takeoff and landing area that would be part of Lilium’s first transportation network in the U.S. — would represent a $25 million investment and, according to the city’s own estimates, generate $1.7 million in economic impact in a 10-year period. (Lilium in September began separately exploring with Germany’s Düsseldorf Airport and Cologne Bonn Airport how to turn the two airports into regional air mobility hubs.)
It’s seemingly a smart time for Lilium — whose planes aren’t expected to be up and running until 2025 — to be talking with cities about additional airport revenue. Passenger traffic has fallen through the floor, owing to the pandemic, and cargo traffic has not been immune, either. Meanwhile, 95% of revenue from airports comes from aeronautical and non-aeronautical services.
Lilium also has a little more spending money after raising $35 million in fresh funding in June led by Baillie Gifford, the largest investor in Tesla — a round that brought the company’s total funding to date to $375 million.
Earlier investors in the company include Atomico, Tencent Holdings and Freigeist.
We sat down with Atomico founder Niklas Zennström in late 2016 when the firm had just led a €10 million Series A in Lilium. At the time, the bet seemed early, despite the existence of rivals like Terrafugia and AeroMobile, yet such vehicles may be an everyday reality sooner than imagined. Investors and founders seem to think so, at least. There are now at least 15 so-called flying cars and taxis in development.
Powered by WPeMatico
Warby Parker, valued at $3 billion, raises $245 million in funding
Warby Parker, the optical e-commerce giant, has today announced the close of a $245 million funding round from D1 Capital Partners, Durable Capital Partners, T. Rowe Price and Baillie Gifford.
A source familiar with the company’s finances confirmed to TechCrunch that this brings Warby Parker’s valuation to $3 billion.
The fresh $245 million comes as a combination of a Series F round ($125 million led by Durable Capital Partners in Q2 of this year) and a Series G round ($120 million led by D1 Capital in Q3 of this year). Neither of the two rounds was previously announced.
In the midst of COVID-19, Warby has also pivoted a few facets of its business. For one, the company’s Buy A Pair, Give A Pair program, which has focused on vision services across the globe, pivoted to stopping the spread of COVID-19 in high-risk countries. The company also used their Optical Lab in New York as a distribution center to facilitate the donation of N95 masks to healthcare workers.
The company has also launched a telehealth service for New York customers, allowing them to extend an existing glasses or contacts prescription through a virtual visit with a Warby Parker OD, and expanded its Prescription Check app to new states.
Warby Parker was founded 10 years ago to sell prescription glasses online. At the time, e-commerce was still relatively nascent and the idea of direct-to-consumer glasses was novel, to say the least. By cutting out the cost of physical stores, and competing with an incumbent who had for years enjoyed the luxury of overpricing the product, Warby was able to sell prescription glasses for less than $100/frame.
Of course, it wasn’t as simple as throwing up a few pictures of frames on a website and watching the orders pour in. The company developed a process where customers could order five potential frames to be delivered to their home, try them on, and send them back once they made a selection.
Since, the company has expanded into new product lines, including sunglasses and children’s frames, as well as expanding its footprint with physical stores. In fact, the company has 125 stores across the U.S. and in parts of Canada.
Warby also developed the prescription check app in 2017 to allow users to extend their prescription through a telehealth check up.
In 2019, Warby launched a virtual try-on feature that uses AR to allow customers to see their selected frames on their own face.
The D2C giant, in its 10 years of existence, has balanced its technological innovation with its physical expansion, which could explain its newfound triple-unicorn status. These latest rounds bring Warby Parker’s total funding to $535.5 million.
Powered by WPeMatico
Oscar’s health insurance platform nabs another $225 million
The direct-to-consumer health insurer Oscar has raised another $225 million in its latest, late-stage round of funding as its vision of tech-enabled healthcare services to drive down consumer costs becomes more and more of a reality.
In an effort to prevent a patient’s potential exposure to the novel coronavirus, COVID-19, most healthcare practices are seeing patients remotely via virtual consultations, and more patients are embracing digital health services voluntarily, which reduces costs for insurers and potentially provides better access to basic healthcare needs. Indeed, Oscar now has a $2 billion revenue base to point to and now a fresh pile of cash from which to draw.
“Transforming the health insurance experience requires the creation of personalized, affordable experiences at scale,” said Mario Schlosser, the co-founder and chief executive of Oscar.
Oscar’s insurance customers have the distinction of being among the most active users of telemedicine among all insurance providers in the U.S., according to the company. Around 30% of patients with insurance plans from the company have used telemedical services, versus only 10% of the country as a whole.
The new late-stage funding for Oscar includes new investors Baillie Gifford and Coatue, two late-stage investor that typically come in before a public offering. Other previous investors, including Alphabet, General Catalyst, Khosla Ventures, Lakestar and Thrive Capital, also participated in the round.
With the new funding, Oscar was able to shrug off the latest criticisms and controversies that swirled around the company and its relationship with White House official Jared Kushner as the president prepared its response to the COVID-19 epidemic.
As the Atlantic reported, engineers at Oscar spent days building a standalone website that would ask Americans to self report their symptoms and, if at risk, direct them to a COVID-19 test location. The project was scrapped within days of its creation, according to the same report.
The company now offers its services in 15 states and 29 U.S. cities, with more than 420,000 members in individual, Medicare Advantage and small group products, the company said.
As Oscar gets more ballast on its balance sheet, it may be readying itself for a public offering. The insurer wouldn’t be the first new startup to test public investor appetite for new listings. Lemonade, which provides personal and home insurance, has already filed to go public.
Oscar’s investors and executives may be watching closely to see how that listing performs. Despite its anemic target, the public market response could signal that more startups in the insurance space could make lemonade from frothy market conditions — even as employment numbers and the broader national economy continue to suffer from pandemic-induced economic shocks.
Powered by WPeMatico
Lilium adds $35M from Baillie Gifford at a $1B+ valuation for its electric aircraft taxi service
While most air travel continues to be ground to a halt, a German startup working on what it hopes will be a major breakthrough in flying has raised more funds to continue building its service. Lilium, which is designing an all-electric vertical take-off and landing aircraft that it plans to build into a taxi-style fleet to ferry passengers within and between cities, has picked up an additional $35 million in funding.
The capital is an extension to a $240 million round Lilium announced just in March of this year, and notably brings in a new, high-profile investor to the startup’s cap table: Baillie Gifford, the storied Scottish VC that has backed the likes of Tesla and SpaceX, Spotify and Airbnb, among others. (As we reported in March, the previous $240 million came from existing investors, which include the likes of Tencent, Atomico, Freigeist and LGT.)
Dr Remo Gerber, Lilium’s chief commercial officer, confirmed in an interview that Lilium is in talks to add more to the round. That would be in line with what sources told us last year, when we reported that Lilium was looking to raise more like $400 million-plus.
So far, it brings the total raised by Lilium to more than $375 million, at a valuation that sources very close to the company confirm is now over $1 billion, making it one of the most highly capitalised, and most valuable, of the next-generation aviation hopefuls.
The extra funding is coming at a key time for Lilium, which is playing a long game but also facing a number of immediate-term challenges.
After a technical stumble earlier this year that saw an older prototype burst into flames while some maintenance was being carried out, leading to a pause while the company figured out what happened, Gerber says the company remains on track for its first commercial services. But those will not be for another five years, in 2025. (The plan is for these to be flown by humans, with autonomous “flying vehicles” coming online about a decade later.)
In the meantime, many are bracing themselves for a big hit to the global economy as a result of the coronavirus pandemic, which is slowing down or halting altogether a number of industries, including three key ones that Lilium touches: aviation, manufacturing and travel.
Gerber said that this latest funding injection was both opportunistic and practical: he pointed out that it’s great to have Baillie Gifford as an investor, but it also helps the company shore up its finances for whatever might come next in this period of uncertainty.
“The two are not mutually exclusive,” he said.
The company now employs 450 employees and has seen no layoffs at a time when millions have lost jobs globally, he added. With many on the design side working at home, Lilium also has large spaces, he said, well equipped for socially distanced manufacturing to handle the next phase of the company’s development.
In the meantime, there remain a number of would-be competitors that are also chasing the same opportunity in flying vehicles, aimed at replacing cars in traffic-clogged cities as well as trains and other vehicles both in congested commuter corridors and routes that are uneconomical for other forms of transport.
They include another German startup, Volocopter, which is also designing a new kind of flying taxi-style vehicle and service, and also closed a $94 million round in February; as well as Kitty Hawk, eHang, Joby and Uber, in addition to Blade and Skyryse, air taxi services of sorts that offer more conventional helicopters and other vessels in limited launches for those willing to spend the money.
Kitty Hawk just last week ended its moonshot Flyer program to focus more resources and attention on its autonomous flying project, pointing to heightened activity in the space.
Safety issues and designing reliable and efficient vessels have been preoccupations not just for the companies building them, but for regulators. There are signs, however, that there may be more advances on that front too.
In the U.K. for example, the government last month announced a new initiative to back more companies building new and novel forms of air transport, part of its bid to support innovative industries and build more sustainable modes of transport for the future. Those are not green lights for services, of course, but are the first steps in that direction, indications that the government is keen to encourage and explore and support getting these ideas off the ground (so to speak).
Lilium sees opportunities both in the U.K. — buffered by Baillie Gifford’s backing out of Edinburgh in Scotland — as well as across Europe and beyond.
“We are delighted to support the remarkable team at Lilium in their ambition of developing a new mode of transport,” said Michael Pye, investment manager at Baillie Gifford, in a statement. “While still at an early stage, we believe this technology could have profound and far-reaching benefits in a low-carbon future and we are excited to watch Lilium’s progress in the years ahead.”
Powered by WPeMatico
Ginkgo Bioworks’ dev shop for genetic programming is now worth $4 billion
Ginkgo Bioworks is now worth $4 billion after a $290 million capital infusion that will give the company the cash to dramatically expand its developer shop for genetic programming.
The Boston-based company is one of a handful of U.S.-based early-stage companies that are on the forefront of developing the tools to modify genetic material for everyday applications.
“Cells are programmable similar to computers because they run on digital code in the form of DNA,” said Jason Kelly, CEO and co-founder of Ginkgo Bioworks, in a statement. “Ginkgo has the best compiler and debugger for writing genetic code and we use it to program cells for customers in a range of industries. Today’s fundraise will allow us to expand our technology and continue our drive to bring biology into every physical goods industry — materials, clothing, electronics, food, pharmaceuticals and more. They are all biotech industries but just don’t know it yet.”
Ginkgo makes money in two ways. The company sells its development services to anyone who comes in with an idea. Kelly said that it’d be like any agreement with an entrepreneur who hires a coding shop to develop an application.
For example, if an entrepreneur wanted to develop houseplants that smelled like roses or lilies, they could approach Ginkgo, pay a (not-insignificant) fee and Ginkgo would do the research into designing something like a lily-scented fern. (Kelly puts the sticker price on that kind of development somewhere in the neighborhood of $10 million, so a founder best believe their product can sell.)
“You don’t need to come in with deep biological know-how,” Kelly says. “The question is, is capital interested in the problem?”
The other way that Ginkgo is approaching the market is by taking equity stakes in businesses that rely on its technology.
Those take the form of joint ventures with companies like Bayer (the first joint venture partner for Ginkgo) and the launch of Joyn, a $100 million spin-out that was created in the summer of 2018.
The two companies are collaborating on the development of seeds that require less fertilizer for growth — something that could save the industry millions and decrease pollution associated with traditional chemical fertilizers.
Since that first spin-out, Ginkgo has created three other companies and joint ventures. There’s the $122 million deal to produce rare cannabinoids with the Canadian cannabis company, Cronos; a partnership with Roche that was born out of Ginkgo’s acquisition of Warp Drive Bio; and Motif Foodworks, which is working on manufacturing alternative proteins with a $120 million in financing.*
Alongside these large-scale initiatives, Ginkgo has signed partnerships with the West Coast powerhouse accelerator program from Y Combinator and a new Boston-based life sciences-focused group called Petri to conduct development work for startups from those programs in exchange for an equity stake.
“We’re not going to have all the good ideas,” says Kelly. “We want to tap the much larger pool of smart people and really have them building on our platform. Of all of the people we can give value to, we can give the most to startups. If we can offer them to do their biowork without all of the fixed costs of building a lab,” that’s valuable, he says.
Investors in the company include Y Combinator, DCVC, MassChallenge, Felicis Ventures, General Atlantic, Baillie Gifford, Bill Gates and Viking Global.
* An earlier version of this article mentioned three company spinouts. The collaborations with Roche and Cronos are not independent companies.
Powered by WPeMatico
Why Carbon just raised another $260 million
Two months ago, we reported that Carbon was set to raise up to $300 million, bringing the 3D printing company’s valuation up to a lofty $2.5 billion. The real numbers released this week by the company aren’t quite so lofty, but are impressive nonetheless. The Series E fetched $260 million, putting its valuation at closer to $2.4 billion.
The latest round follows a $200 million Series D that arrived in late-2017, bringing the company’s total raise to $680 million. What exactly is the bay area-based startup planning to do with that massive sum, in the wake of high profile manufacturing partnerships with companies like Adidas and Riddell?
CEO/co-founder Joseph M. DeSimone and recent addition CMO Dara Treseder (most recently of GE Ventures) stopped by our offices to discuss what the latest round means for the Bay Area-based company.
Asked for a timeline around when Carbon might exit, DeSimon offered a non-committal answer. “As we grow our business, we haven’t made announcements for our IPO or anything like that yet,” he told TechCrunch. But the revenue business is growing nicely. So we’re in pretty good shape.”
It’s hard to say precisely what goals the company is hoping to attain before going public, but at the very least, Carbon presents a good indicator that the 3D printing industry is back on the uptick — in some circles, at least.
Powered by WPeMatico
Groupon co-founder Eric Lefkofsky just raised another $200 million for his newest company, Tempus
When serial entrepreneur Eric Lefkofsky grows a company, he puts the pedal to the metal. When in 2011 his last company, the Chicago-based coupons site Groupon, raised $950 million from investors, it was the largest amount raised by a startup, ever. It was just over three years old at the time, and it went public later that same year.
Lefkofsky seems to be stealing a page from the same playbook for his newest company, Tempus. The Chicago-based genomic testing and data analysis company was founded a little more than three years ago, yet it has already hired nearly 700 employees and raised more than $500 million — including through a new $200 million round that values the company at $3.1 billion.
According to the Chicago Tribune, that new valuation makes it — as Groupon once was — one of Chicago’s most highly valued privately held companies.
So why all the fuss? As the Tribune explains it, Tempus has built a platform to collect, structure and analyze the clinical data that’s often unorganized in electronic medical record systems. The company also generates genomic data by sequencing patient DNA and other information in its lab.
The goal is to help doctors create customized treatments for each individual patient, Lefkofsky tells the paper.
So far, it has partnered with numerous cancer treatment centers that are apparently giving Tempus human data from which to learn. Tempus is also generating data “in vitro,” as is another company we featured recently called Insitro, a drug development startup founded by famed AI researcher Daphne Koller. With Insitro, it is working on a liver disease treatment owing to a tie-up with Gilead, which has amassed related human data over the years from which Insitro can use to learn. As a complementary data source, Insitro, like Tempus, is trying to learn what the disease does in a “dish,” then determine if it can use what it observes using machine learning to predict what it sees in people.
Tempus hasn’t come up with any cancer-related cures yet, but Lefkofsky already says that Tempus wants to expand into diabetes and depression, too.
In the meantime, he tells Crain’s Chicago Business that Tempus is already generating “significant” revenue. “Our oldest partners, have, in most cases, now expanded to different subgroups (of cancer). What we’re doing is working.”
Investors in the latest round include Baillie Gifford; Revolution Growth; New Enterprise Associates; funds and accounts managed by T. Rowe Price; Novo Holdings; and the investment management company Franklin Templeton.
Powered by WPeMatico
WTF is Baillie Gifford?
The SoftBank Vision Fund has been screaming from the venture headlines the last few months, driven by eye-popping rounds (and valuations!) into some of the most notable startups around the world. Yet, SoftBank isn’t the only player rapidly buying up the cap tables of top startups. Indeed, another firm, more than a century old, has been fighting for that late-stage equity crown.
… Who the what?
When our fintech contributor Gregg Schoenberg interviewed Charles Plowden, the firm’s joint senior partner, about the firm’s prodigious investing, we realized that we have never gone in-depth on one of the most influential investors in Silicon Valley. So here goes.
Baillie Gifford is a 110-year-old asset management firm based out of Edinburgh, Scotland, and has long had a penchant for pre-IPO tech companies. The firm was an early investor into some of the world’s most valuable private and public tech companies, boasting a roster of portfolio companies that includes unicorns from nearly all generations in modern tech, including everything from Amazon, Google and Salesforce to Tesla, Airbnb, Spotify, newly public Lyft, Palantir and even SpaceX.
Baillie Gifford’s reach stretches way beyond the 280/101 corridor. The firm has an extensive history of investing across geographies, with one of its first and most successful investments coming from an early entry into Chinese e-commerce titan Alibaba. More recently, Baillie Gifford even held a stake in recently IPO’d Chinese electric autonomous vehicle manufacturer NIO, and one the firm’s largest current holdings is South African internet conglomerate Naspers — which itself is an active investor and developer of emerging market tech infrastructure.
The firm’s low profile belies its aggressive capital deployment strategy. According to data from PitchBook, Baillie Gifford was involved in roughly 20 deals in 2018 and was involved as a lead or participant in transactions worth over $21 billion in aggregate total deal size — beating out behemoth Tiger Global, which tallied roughly $13.25 billion on the same metric.
The firm has about $2 billion focused on private companies, so while it is aggressive in getting into later-stage rounds, it is not nearly operating at the scale of say the Vision Fund or Tiger Global. While the asset manager primarily focuses on public-equity investing, the firm has participated in investment rounds as early as Series A, according to PitchBook and Crunchbase data.
Overall, the firm manages $221 billion in assets under management as of January 2019.
As one of the earliest asset managers to invest in pre-IPO tech companies, Baillie Gifford has sourced investments through its longstanding reputation as an investor. The firm first began really diving into private tech investing in the wake of the dot-com bubble. The firm doubled down on the tech sector at a time when few others were investing and sifted through the blood bath to find cheap entryways into companies that are now amongst the world’s largest.
Today, however, the landscape is undoubtedly much different. Tech companies now make up four of the top five largest companies in the world by market cap, and seven out of the top 10. Now, everyone wants a piece of the pie and there seem to be more checks being thrown at founders than most can even fit in their wallets.
With more capital at their fingertips than ever before, founders are opting to keep their startups private for longer in order to avoid the stress of having to deal with short-term public market investors who are more often than not looking for the first opportunity to cash out. So why, amongst so much choice, do companies continue to partner with Baillie Gifford?
Plowden has some insights on that front in our interview, but the summary is that Baillie Gifford just sees itself as a partner. Unlike its peers and most investment managers, Baillie Gifford has no outside shareholder owners to report to. As a partnership, wholly owned and run by just 44 partners, the firm doesn’t face the organizational constraints that beset most firms that manage billions and billions in assets.
The result? In short, Baillie Gifford has quietly been making a killing, and probably drinking some good Scotch along the way, as well.
Powered by WPeMatico
Baillie Gifford’s Charles Plowden on 110 years of investing
“It is our contention that the investment industry may be experiencing a peak of its own, in this case the point of the maximum rate at which it extracts value from its clients’ assets. Let’s call it Peak Gravy.” That’s a recent quote from Tom Coutts, who is one of a few dozen partners at Baillie Gifford (See Arman Tabatabai’s profile here). It’s also typical of the provocative sentiments offered by this band of fund managers who are based in Edinburgh, but scour the world looking for opportunities.
In an effort to distinguish its world view, the firm has introduced the somewhat eyebrow-raising tagline, “We’re actual investors.” For many US technology observers, though, Baillie Gifford is known for its investments in unicorns. But as Extra Crunch’s executive editor Danny Crichton and I found out in a recent conversation with Charles Plowden (one of two senior partners and the overseer of the firm’s investment departments), there’s a lot more to the story and motivations behind this unique 110-year-old partnership that’s still going strong.
Powered by WPeMatico